Muscle pain treated with injected normal saline solution
Pain comes in all shapes and sizes. Ranging from acute to chronic, from nociceptive and myofascial to neuropathic, pain is a part of life. Myofascial or muscle pain, is among the most common. With a lifetime prevalence of up to 85%, it affects nearly all of us at some point in our lives. This type of pain does not represent a threat to life or limb. However, does pose a substantial threat to the quality of life. Myofascial pain is commonly the result of trauma and repetitive muscle stress, but can also result from malnutrition, poor posture, and even poor sleep hygiene, to name a few.
Typical features of myofascial pain include a referred pain or pain located distantly from the muscle compromised. This referred pain is specific to each muscle and commonly known as “the muscle signature”. This can mimic other conditions (i.e., pain originating on a quadratus lumborum muscle can resemble appendicitis and other lower abdominal pathologies) (Table 1, Fig. 1). This can result in unnecessary workups and poor pain control. Another feature of myofascial pain is the presence of a trigger point, a localized, hyperirritable taut band of fibers in the belly of the compromised muscle. When stimulated, the TP reproduces the symptoms including the referred pain.
Although multiple approaches to the management of myofascial pain have been used, trigger point injections (TPIs) are considered more effective and therefore are more commonly used. Conventional medications used in TPIs involve a steroid mixed with a local anesthetic. However, injections of corticosteroid solutions can result in localized skin thinning, muscle atrophy, and even improper hormone regulation. We compared TPIs utilizing normal saline solution versus a conventional active drug mixture on patients presenting with myofascial pain in the emergency department.
In our randomized, controlled, blind non-inferiority trial, we enrolled 51 patients with myofascial pain to undergo TPIs with either a conventional mixture (Bupivacaine + Triamcinolone) or 0.9% normal saline. After undergoing TPIs, the patients were assessed using the Numeric Rating Scale of pain (0-10), with 0 being no pain and 10 being the worst imaginable. Additionally, patients were rated on a Likert scale, measuring satisfaction from 1 (dissatisfied) to 5 (very satisfied). The mean pain scores on initial presentation for patients in the conventional medication and normal saline groups were 8.92 and 8.73, respectively. Pain scores taken immediately following TPIs and then at discharge. For the conventional drug and normal saline groups illustrated a reduction of 5.68 and 5.48 and then 5.96 and 6.17, respectively. While this led us to conclude that TPIs, as a treatment of myofascial pain are effective, it didn’t elucidate a notable difference between the two modalities. Subsequent follow-up at two weeks after TPIs demonstrated a mean pain score decrease of 3.09 and 3.05 for the conventional medication and normal saline groups, respectively (Fig. 2). Interestingly, the patient satisfaction was higher on those receiving TPIs with normal saline.
This study concurred with previous studies in demonstrating non-inferiority between normal saline and conventional drug mixtures in the treatment of myofascial pain. The favorable adverse effect profile of normal saline, along with being very cost effective, make it an attractive option for the treatment of myofascial pain syndrome.
Warner K, Roldan CJ
Pain Medicine MD Anderson Cancer Center, USA
Normal Saline Trigger Point Injections vs Conventional Active Drug Mix for Myofascial Pain Syndromes
Carlos J Roldan, Uzondu Osuagwu, Marylou Cardenas-Turanzas, Billy K Huh
Am J Emerg Med. 2020 Feb